{"id":27929,"date":"2024-10-28T15:26:36","date_gmt":"2024-10-28T14:26:36","guid":{"rendered":"https:\/\/ggba.swiss\/onward-medical-raises-eur-50-million-and-welcomes-a-new-strategic-partner\/"},"modified":"2024-10-28T15:29:11","modified_gmt":"2024-10-28T14:29:11","slug":"onward-medical-leve-eur-50-millions-et-accueille-un-nouveau-partenaire-strategique","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/fr\/onward-medical-leve-eur-50-millions-et-accueille-un-nouveau-partenaire-strategique\/","title":{"rendered":"ONWARD Medical l\u00e8ve EUR 50 millions et accueille un nouveau partenaire strat\u00e9gique"},"content":{"rendered":"\n<p><a href=\"file:\/\/\/B:\/Users\/pierre-yves.oehrli\/Desktop\/En%20cours\/\u00ab\">ONWARD Medical<\/a>, leader dans les th\u00e9rapies de stimulation de la moelle \u00e9pini\u00e8re, a lev\u00e9 EUR 50 millions par le biais d&rsquo;un placement priv\u00e9 \u00e9largi aupr\u00e8s d&rsquo;investisseurs institutionnels, s&rsquo;assurant ainsi une marge de man\u0153uvre substantielle pour les deux prochaines ann\u00e9es. Cette augmentation de capital refl\u00e8te une forte demande et soutient la mission d&rsquo;ONWARD de restaurer le mouvement, la fonction et l&rsquo;ind\u00e9pendance des personnes souffrant de l\u00e9sions de la moelle \u00e9pini\u00e8re. Ce dernier financement \u00e9tablit \u00e9galement un partenariat strat\u00e9gique avec <a href=\"https:\/\/corporate.ottobock.com\/en\/home\">Ottobock<\/a>, un innovateur mondial en mati\u00e8re de proth\u00e8ses, d&rsquo;orth\u00e8ses et d&rsquo;exosquelettes, qui a acquis environ 10 % du capital social d&rsquo;ONWARD.<\/p>\n\n\n\n<p>En outre, ONWARD a r\u00e9cemment lev\u00e9 EUR 20 millions par le biais d&rsquo;un placement priv\u00e9 et d&rsquo;une introduction en bourse afin de soutenir le d\u00e9veloppement de produits, les essais cliniques et le lancement pr\u00e9vu aux Etats-Unis de son syst\u00e8me ARC-EX pour la restauration des fonctions de la main et du bras. Ces r\u00e9alisations ont renforc\u00e9 la position financi\u00e8re d&rsquo;ONWARD et sa capacit\u00e9 \u00e0 faire progresser les th\u00e9rapies de pointe dans le traitement des l\u00e9sions de la moelle \u00e9pini\u00e8re.<\/p>\n\n\n\n<p>Ce partenariat avec Ottobock, soci\u00e9t\u00e9 ayant plus de 100 ans d&rsquo;expertise dans les solutions de mobilit\u00e9, a pour objectif d&rsquo;explorer le d\u00e9veloppement conjoint et les opportunit\u00e9s commerciales. \u00ab Nous sommes ravis d&rsquo;accueillir Ottobock en tant qu&rsquo;investisseur et partenaire strat\u00e9gique \u00bb, a d\u00e9clar\u00e9 Dave Marver, CEO d&rsquo;ONWARD. \u00ab Leur expertise correspond \u00e0 notre mission et nous sommes impatients de collaborer \u00e0 l&rsquo;\u00e9largissement de notre gamme de th\u00e9rapies r\u00e9volutionnaires. \u00bb Le pr\u00e9sident d&rsquo;Ottobock, le professeur Hans Georg N\u00e4der, a exprim\u00e9 un optimisme similaire, soulignant le potentiel d&rsquo;ONWARD \u00e0 devenir un \u00ab changeur de jeu \u00bb dans la th\u00e9rapie des l\u00e9sions m\u00e9dullaires.<\/p>\n\n\n\n<p>ONWARD pr\u00e9voit d&rsquo;utiliser les fonds pour faire avancer la recherche et le d\u00e9veloppement, en particulier pour ses syst\u00e8mes ARC-EX, ARC-IM et ARC-BCI. L&rsquo;investissement soutiendra \u00e9galement le lancement commercial de l&rsquo;ARC-EX aux \u00c9tats-Unis, l&rsquo;expansion de l&rsquo;infrastructure op\u00e9rationnelle et les opportunit\u00e9s strat\u00e9giques qui peuvent inclure des licences ou des acquisitions.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>ONWARD Medical a lev\u00e9 EUR 50 millions par le biais d&rsquo;un placement priv\u00e9 de grande envergure, \u00e9tablissant un partenariat strat\u00e9gique avec Ottobock. Les fonds permettront \u00e0 ONWARD de poursuivre ses recherches et de commercialiser des th\u00e9rapies pour la moelle \u00e9pini\u00e8re, tout en pr\u00e9voyant une collaboration avec Ottobock pour de futures innovations.<\/p>\n","protected":false},"author":6,"featured_media":27926,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[843],"tags":[1148,1181,1163,1239,1141],"class_list":["post-27929","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sciences-de-la-vie","tag-financing-fr-2","tag-medical-devices-fr","tag-medtech-fr-2","tag-neuroscience-fr-2","tag-personalized-medicine-fr-2"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ONWARD Medical l\u00e8ve EUR 50 millions | GGBa<\/title>\n<meta name=\"description\" content=\"ONWARD a lev\u00e9 EUR 50 millions par le biais d&#039;un placement priv\u00e9 de grande envergure, \u00e9tablissant un partenariat strat\u00e9gique avec Ottobock.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/fr\/onward-medical-leve-eur-50-millions-et-accueille-un-nouveau-partenaire-strategique\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ONWARD Medical l\u00e8ve EUR 50 millions | GGBa\" \/>\n<meta property=\"og:description\" content=\"ONWARD a lev\u00e9 EUR 50 millions par le biais d&#039;un placement priv\u00e9 de grande envergure, \u00e9tablissant un partenariat strat\u00e9gique avec Ottobock.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/fr\/onward-medical-leve-eur-50-millions-et-accueille-un-nouveau-partenaire-strategique\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2024-10-28T14:26:36+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-10-28T14:29:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ggba.swiss\/app\/uploads\/2024\/10\/Onward-Arc-1180x811-1.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1180\" \/>\n\t<meta property=\"og:image:height\" content=\"811\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pierre-Yves Oehrli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pierre-Yves Oehrli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/fr\/onward-medical-leve-eur-50-millions-et-accueille-un-nouveau-partenaire-strategique\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/onward-medical-leve-eur-50-millions-et-accueille-un-nouveau-partenaire-strategique\/\"},\"author\":{\"name\":\"Pierre-Yves Oehrli\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"headline\":\"ONWARD Medical l\u00e8ve EUR 50 millions et accueille un nouveau partenaire strat\u00e9gique\",\"datePublished\":\"2024-10-28T14:26:36+00:00\",\"dateModified\":\"2024-10-28T14:29:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/onward-medical-leve-eur-50-millions-et-accueille-un-nouveau-partenaire-strategique\/\"},\"wordCount\":386,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/onward-medical-leve-eur-50-millions-et-accueille-un-nouveau-partenaire-strategique\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/10\/Onward-Arc-1180x811-1.jpeg\",\"keywords\":[\"Financing\",\"Medical Devices\",\"Medtech\",\"Neuroscience\",\"Personalized Medicine\"],\"articleSection\":[\"Sciences de la vie\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ggba.swiss\/fr\/onward-medical-leve-eur-50-millions-et-accueille-un-nouveau-partenaire-strategique\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/fr\/onward-medical-leve-eur-50-millions-et-accueille-un-nouveau-partenaire-strategique\/\",\"url\":\"https:\/\/ggba.swiss\/fr\/onward-medical-leve-eur-50-millions-et-accueille-un-nouveau-partenaire-strategique\/\",\"name\":\"ONWARD Medical l\u00e8ve EUR 50 millions | GGBa\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/onward-medical-leve-eur-50-millions-et-accueille-un-nouveau-partenaire-strategique\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/onward-medical-leve-eur-50-millions-et-accueille-un-nouveau-partenaire-strategique\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/10\/Onward-Arc-1180x811-1.jpeg\",\"datePublished\":\"2024-10-28T14:26:36+00:00\",\"dateModified\":\"2024-10-28T14:29:11+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"description\":\"ONWARD a lev\u00e9 EUR 50 millions par le biais d'un placement priv\u00e9 de grande envergure, \u00e9tablissant un partenariat strat\u00e9gique avec Ottobock.\",\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/onward-medical-leve-eur-50-millions-et-accueille-un-nouveau-partenaire-strategique\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/fr\/onward-medical-leve-eur-50-millions-et-accueille-un-nouveau-partenaire-strategique\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ggba.swiss\/fr\/onward-medical-leve-eur-50-millions-et-accueille-un-nouveau-partenaire-strategique\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/10\/Onward-Arc-1180x811-1.jpeg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/10\/Onward-Arc-1180x811-1.jpeg\",\"width\":1180,\"height\":811,\"caption\":\"L'interface cerveau-ordinateur d'ONWARD d\u00e9tecte les signaux c\u00e9r\u00e9braux indiquant les mouvements souhait\u00e9s chez les patients paralys\u00e9s, et des algorithmes d'intelligence artificielle envoient ces signaux au stimulateur de moelle \u00e9pini\u00e8re ARC-IM pour d\u00e9clencher des mouvements dans les bras, les mains ou les doigts. | \u00a9 ONWARD Medical\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/fr\/onward-medical-leve-eur-50-millions-et-accueille-un-nouveau-partenaire-strategique\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ONWARD Medical l\u00e8ve EUR 50 millions et accueille un nouveau partenaire strat\u00e9gique\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\",\"name\":\"Pierre-Yves Oehrli\",\"url\":\"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ONWARD Medical l\u00e8ve EUR 50 millions | GGBa","description":"ONWARD a lev\u00e9 EUR 50 millions par le biais d'un placement priv\u00e9 de grande envergure, \u00e9tablissant un partenariat strat\u00e9gique avec Ottobock.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/fr\/onward-medical-leve-eur-50-millions-et-accueille-un-nouveau-partenaire-strategique\/","og_locale":"fr_FR","og_type":"article","og_title":"ONWARD Medical l\u00e8ve EUR 50 millions | GGBa","og_description":"ONWARD a lev\u00e9 EUR 50 millions par le biais d'un placement priv\u00e9 de grande envergure, \u00e9tablissant un partenariat strat\u00e9gique avec Ottobock.","og_url":"https:\/\/ggba.swiss\/fr\/onward-medical-leve-eur-50-millions-et-accueille-un-nouveau-partenaire-strategique\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2024-10-28T14:26:36+00:00","article_modified_time":"2024-10-28T14:29:11+00:00","og_image":[{"width":1180,"height":811,"url":"https:\/\/ggba.swiss\/app\/uploads\/2024\/10\/Onward-Arc-1180x811-1.jpeg","type":"image\/jpeg"}],"author":"Pierre-Yves Oehrli","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Pierre-Yves Oehrli","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/fr\/onward-medical-leve-eur-50-millions-et-accueille-un-nouveau-partenaire-strategique\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/fr\/onward-medical-leve-eur-50-millions-et-accueille-un-nouveau-partenaire-strategique\/"},"author":{"name":"Pierre-Yves Oehrli","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"headline":"ONWARD Medical l\u00e8ve EUR 50 millions et accueille un nouveau partenaire strat\u00e9gique","datePublished":"2024-10-28T14:26:36+00:00","dateModified":"2024-10-28T14:29:11+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/onward-medical-leve-eur-50-millions-et-accueille-un-nouveau-partenaire-strategique\/"},"wordCount":386,"commentCount":0,"image":{"@id":"https:\/\/ggba.swiss\/fr\/onward-medical-leve-eur-50-millions-et-accueille-un-nouveau-partenaire-strategique\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/10\/Onward-Arc-1180x811-1.jpeg","keywords":["Financing","Medical Devices","Medtech","Neuroscience","Personalized Medicine"],"articleSection":["Sciences de la vie"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ggba.swiss\/fr\/onward-medical-leve-eur-50-millions-et-accueille-un-nouveau-partenaire-strategique\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/fr\/onward-medical-leve-eur-50-millions-et-accueille-un-nouveau-partenaire-strategique\/","url":"https:\/\/ggba.swiss\/fr\/onward-medical-leve-eur-50-millions-et-accueille-un-nouveau-partenaire-strategique\/","name":"ONWARD Medical l\u00e8ve EUR 50 millions | GGBa","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/onward-medical-leve-eur-50-millions-et-accueille-un-nouveau-partenaire-strategique\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/fr\/onward-medical-leve-eur-50-millions-et-accueille-un-nouveau-partenaire-strategique\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/10\/Onward-Arc-1180x811-1.jpeg","datePublished":"2024-10-28T14:26:36+00:00","dateModified":"2024-10-28T14:29:11+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"description":"ONWARD a lev\u00e9 EUR 50 millions par le biais d'un placement priv\u00e9 de grande envergure, \u00e9tablissant un partenariat strat\u00e9gique avec Ottobock.","breadcrumb":{"@id":"https:\/\/ggba.swiss\/fr\/onward-medical-leve-eur-50-millions-et-accueille-un-nouveau-partenaire-strategique\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/fr\/onward-medical-leve-eur-50-millions-et-accueille-un-nouveau-partenaire-strategique\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ggba.swiss\/fr\/onward-medical-leve-eur-50-millions-et-accueille-un-nouveau-partenaire-strategique\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2024\/10\/Onward-Arc-1180x811-1.jpeg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/10\/Onward-Arc-1180x811-1.jpeg","width":1180,"height":811,"caption":"L'interface cerveau-ordinateur d'ONWARD d\u00e9tecte les signaux c\u00e9r\u00e9braux indiquant les mouvements souhait\u00e9s chez les patients paralys\u00e9s, et des algorithmes d'intelligence artificielle envoient ces signaux au stimulateur de moelle \u00e9pini\u00e8re ARC-IM pour d\u00e9clencher des mouvements dans les bras, les mains ou les doigts. | \u00a9 ONWARD Medical"},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/fr\/onward-medical-leve-eur-50-millions-et-accueille-un-nouveau-partenaire-strategique\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/fr\/"},{"@type":"ListItem","position":2,"name":"ONWARD Medical l\u00e8ve EUR 50 millions et accueille un nouveau partenaire strat\u00e9gique"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41","name":"Pierre-Yves Oehrli","url":"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/27929","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/comments?post=27929"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/27929\/revisions"}],"predecessor-version":[{"id":27931,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/27929\/revisions\/27931"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media\/27926"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media?parent=27929"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/categories?post=27929"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/tags?post=27929"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}